Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower Limb Lymphedema: Aim 4

Recruiting Observational Study
Lower Limb Lymphedema
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
120 (estimated)
Sponsor
KU Leuven · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Research investigating measurement properties for evaluating the decongestive treatment effect on different edema characteristics (e.g. water volume, hardness of the skin, water content,..) at the level of the lower limbs is missing. Information about the clinical relevant change criteria after treatment for nearly all these edema characteristics, is not present and requires investigation. To ass…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Intensive treatment group * Unilateral or bilateral, primary or secondary LLL * No active metastases * If cancer-related lymphedema, time interval since surgery/ radiotherapy/ chemotherapy is ≥3 months * Objective diagnosis of lymphedema: ≥ 5% volume difference OR ≥ 2…
Contacts

Tessa De Vrieze, Dr.

003216345006

tessa.devrieze@kuleuven.be

CONTACT

Nele Devoogdt, Prof. Dr.

0032 16 342515

nele.devoogdt@kuleuven.be

CONTACT